2026 NPPES data Dermatology Physician NPI 1134222599 MD
Verify on CMS →

NORMA SCHMITZ, MD

Dermatology Physician in TERRE HAUTE, Indiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 966 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
96%
generic claims · 4% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
83.2279/100
▲ 0 pts above national avg 83.1 · [object Object]
Industry payments
$574.48
18 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

NORMA SCHMITZ, MD reported a CMS MIPS final score of 83.2279/100 — above the 83.1 national average — and filed 2,824 Medicare Part D claims in 2023.

83.2279/100
MIPS score · +0 vs avg
3K
Part D claims, 2023
96%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NORMA SCHMITZ, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

83 42nd percentile higher than 42% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

NORMA SCHMITZ, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about NORMA SCHMITZ, MD?

Near national average

NPI registry status

Active

Issued 09/07/2006

NPI 1134222599

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

2,824 287% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

83.2279/100 0.127900000000011% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Indiana

How Dermatology Physician compares to other specialties among Indiana providers

Indiana providers

Dermatology Physician share within Indiana

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Indiana

Medicare quality performance — MIPS

NORMA SCHMITZ, MD's 2023 MIPS final score plotted against the Dermatology Physician national average

Near national average
MIPS Final Score
83.2279/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 83.2279/100 vs national avg 83.1

0%100%National avg83%83.2%
MIPS final score (Dermatology Physician) — 83.2279/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NORMA SCHMITZ, MD appears in the CMS NPPES registry as a Dermatology Physician provider holding MD credentials at 1202 E CANVASBACK DR, TERRE HAUTE, IN, 47802, with a listed phone of (812) 299-3376. NPI 1134222599 was issued on 09/07/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SCHMITZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,824 prescription claims written by this provider, covering 966 Medicare beneficiaries and totaling roughly $325K in drug spend, split 4% brand-name and 96% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 83.2279/100 for the 2023 performance year (Quality 100, Cost 44.0931), compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1202 E CANVASBACK DR
TERRE HAUTE, IN 47802

Provider Details

NPI 1134222599
Specialty Dermatology Physician
Credentials MD
Gender Female
NPI Issued 09/07/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

83.2279
Final Score
Avg: 83.1
100
Quality
44.0931
Cost

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NORMA SCHMITZ, MD. Source: openpaymentsdata.cms.gov.

Total received

$574

Largest payer

Regeneron Healthcare Solutions, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

NORMA SCHMITZ, MD — brand share 4.0%
Specialty average (est.)

4% brand-name claims vs 96% generic, on 2,824 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,824
Total Claims
$325K
Total Drug Cost
966
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,095
Total Day Supply
74,469
Brand vs Generic
4% brand / 96% generic
Brand Drug Cost
$256K
Generic Drug Cost
$68K
Antibiotic Claims
508

Patient Demographics

Average Patient Age
76.9 years
Avg HCC Risk Score
1.13
Gender Split
63% female / 37% male
Age Distribution
<65: 19, 65-74: 368, 75-84: 406, 85+: 173

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What NORMA SCHMITZ, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ketoconazole
544
Hydrocortisone
413
Triamcinolone Acetonide
220
Amoxicillin
169
Clobetasol Propionate
166
Doxycycline Hyclate
163
Fluticasone Propionate
159
Mupirocin
144
Minocycline Hcl
78
Metronidazole
74

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How NORMA SCHMITZ, MD fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

NORMA SCHMITZ, MD's 2,824 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in Indiana

Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as SCHMITZ.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NORMA SCHMITZ, MD's specialty?
NORMA SCHMITZ, MD specializes in Dermatology Physician and practices in TERRE HAUTE, Indiana. Credentials: MD.
How much does NORMA SCHMITZ, MD prescribe under Medicare Part D?
In 2023, NORMA SCHMITZ, MD wrote 2,824 Medicare Part D claims totaling $325K in drug costs for 966 beneficiaries.
What is NORMA SCHMITZ, MD's Medicare quality score?
NORMA SCHMITZ, MD has a CMS MIPS Final Score of 83.2279/100 (Quality: 100, Cost: 44.0931). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is NORMA SCHMITZ, MD located?
NORMA SCHMITZ, MD is located at 1202 E CANVASBACK DR, TERRE HAUTE, IN, 47802. Phone: (812) 299-3376.
What is NORMA SCHMITZ, MD's NPI number?
NORMA SCHMITZ, MD's National Provider Identifier (NPI) is 1134222599, issued on 09/07/2006.
Does NORMA SCHMITZ, MD prescribe more brand-name or generic drugs?
NORMA SCHMITZ, MD's prescribing is 4% brand-name and 96% generic drugs by claim count, with $256K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does NORMA SCHMITZ, MD prescribe most often?
Based on 2023 Medicare Part D data, NORMA SCHMITZ, MD's most frequently prescribed drugs include Ketoconazole, Hydrocortisone, Triamcinolone Acetonide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NORMA SCHMITZ, MD accept Medicare?
NORMA SCHMITZ, MD appears in CMS Medicare data with 2,824 Part D claims and 966 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NORMA SCHMITZ, MD's credentials?
NORMA SCHMITZ, MD's NPI is 1134222599 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology